EVALUATION OF TIOTROPIUM 2.5 AND 5 MCG ONCE DAILY DELIVERED VIA THE RESPIMAT® INHALER COMPARED TO PLACEBO AND SALMETEROL HYDROFLUOROALKANE (HFA) METERED DOSE INHALER (MDI) (50 MCG TWICE DAILY) IN PATIENT WITH MODERATE PERSISTENT ASTHMA I: